Provided by Tiger Trade Technology Pte. Ltd.

Galera Therapeutics, Inc.

0.0240
-0.0012-4.76%
Volume:53.28K
Turnover:1.34K
Market Cap:1.81M
PE:-0.10
High:0.0283
Open:0.0240
Low:0.0240
Close:0.0252
52wk High:0.0598
52wk Low:0.0151
Shares:75.46M
Float Shares:56.72M
Volume Ratio:0.95
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2462
EPS(LYR):-0.3470
ROE:-1063.11%
ROA:-55.36%
PB:-0.01
PE(LYR):-0.07

Loading ...

Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Major Issues Report

Form 8-K - Current report
Oct 21, 2025

Major Issues Report

Form 8-K - Current report
Sep 03, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 03, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 31, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Sep 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations